Search Prime Grants

NU50CK000576

Cooperative Agreement

Overview

Grant Description
Optimization of the pharmacist's role to prevent and control emerging and re-emerging infectious disease threats.
Awardee
American Pharmacists Association
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
93.318 - Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security
Awarding Agency
CDC Office of Financial Resources (OFR) [HHS - CDC]
Funding Agency
National Center for Immunization and Respiratory Diseases (NCRID) [HHS - CDC]
Place of Performance
Washington, District Of Columbia United States
Geographic Scope
City-Wide
Related Opportunity
Improving Clinical and Public Health Outcomes through National Partnerships to Prevent and Control Emerging and Re-Emerging Infectious Disease Threats (CDC-RFA-CK20-2003)
Analysis Notes
COVID-19 $1,750,000 (27%) percent of this Cooperative Agreement was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021 and the Consolidated Appropriations Act of 2021.
Amendment Since initial award the End Date has been shortened from 09/29/25 to 06/29/24 and the total obligations have increased 117% from $3,000,000 to $6,500,000.
American Pharmacists Association was awarded Pharmacist's Role in Infectious Disease Control Cooperative Agreement NU50CK000576 worth $6,500,000 from National Center for Immunization and Respiratory Diseases in February 2021 with work to be completed primarily in Washington District Of Columbia United States. The grant has a duration of 3 years 4 months and was awarded through assistance program 93.318 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security. The Cooperative Agreement was awarded through grant opportunity Improving Clinical and Public Health Outcomes through National Partnerships to Prevent and Control Emerging and Re-Emerging Infectious Disease Threats.

Status
(Complete)

Last Modified 1/5/24

Period of Performance
2/1/21
Start Date
6/29/24
End Date
100% Complete

Funding Split
$6.5M
Federal Obligation
$0.0
Non-Federal Obligation
$6.5M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to NU50CK000576

Transaction History

Modifications to NU50CK000576

Additional Detail

Award ID FAIN
NU50CK000576
SAI Number
NU50CK000576-827586826
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75CDC1 CDC OFFICE OF FINANCIAL RESOURCES
Funding Office
75CVG0 CDC NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES
Awardee UEI
PBHVMVG4BGK4
Awardee CAGE
95225
Performance District
DC-98

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
CDC-Wide Activities and Program Support, Centers for Disease Control and Prevention, Health and Human Services (075-0943) Health care services Grants, subsidies, and contributions (41.0) $1,250,000 63%
CDC-Wide Activities and Program Support, Centers for Disease Control and Prevention, Health and Human Services (075-0943) Health research and training Grants, subsidies, and contributions (41.0) $500,000 25%
Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Health and Human Services (075-0949) Health care services Grants, subsidies, and contributions (41.0) $200,000 10%
Modified: 1/5/24